ZyVersa Therapeutics (Larkspur Health Acquisition) Priced, Nasdaq: ZVSA
Blank check company focused on the US biotechnology sector (completed 12/12/2022).
Industry: SPAC
First Day Return: -0.2%
We are a newly-organized blank check company incorporated in Delaware. While our efforts to identify a target business may span many industries and regions worldwide, we intend to focus our search for prospects within the biotechnology sector in the United States. Our management team is led by Daniel O’Connor, our Chairman and CEO, and David Briones, our CFO and Secretary. Daniel O’Connor is founder and the manager of our sponsor, Larkspur Health.
| IPO Data | |
|---|---|
| IPO Date | 12/20/2021 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Bridgewater, NJ, United States |
| Founded | 2021 |
| Employees at IPO | 2 |
IPO News for ZyVersa Therapeutics (Larkspur Health Acquisition)
ZyVersa Therapeutics (Larkspur Health Acquisition) (ZVSA) Performance
